Home›People›Jonathan Arambula
Jonathan Arambula

Jonathan Arambula

Co-founder, CTO & Executive Chairman at InnovoTEX.

Director
Updated Nov 9, 2026·Latest SEC filing Aug 18, 2026·Suggest an edit

About Jonathan Arambula

Jonathan Arambula is a co-founder, CTO & executive chairman at InnovoTEX.

Experience

This experience comes from Jonathan Arambula's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jonathan Arambula in the role, so the role may have started earlier or lasted longer.

InnovoTEX Inc. Current
Co-founder, CTO & Executive Chairman
Executive Chairman and Co-Founder (2022 – Present)
2022 – Present · Austin, TX
Develops cancer drugs designed to remain in tumors longer for people with cancer.
OncoTEX Inc.
Chief Executive Officer
2019 – 2022
Cible RX
Co-founder
2016 – 2019
Georgia Southern University
Assistant Professor of Chemistry
2014 – 2016
MD Anderson Cancer Center
ACS Postdoctoral Fellow
2009 – 2014

Key Colleagues at Startups

The people Jonathan Arambula works with at each company, as listed on that company's latest Form D.

InnovoTEX Inc. · Form D, Aug 18, 2026
James Hussey
James Hussey
Executive Vice Chairman
Krystle Karoscik
Krystle Karoscik
Co-founder, CEO & Board Director

Sources

  1. SECInnovoTEX Inc. Form D, filed Aug 18, 2026